Modern strategy for new medicine research: study of pharmacological activities of riachin, A non-cyanogenic cyanoglucoside extracted from bauhinia pentandra
AbstractOver the years the search for new molecules is growing, the success of new discoveries often occurs with molecules arising from the nature that subsequently pass through chemical improvements. Unfortunately many of the identified and isolated substances do not reach on to become a drug, a few times a discontinuity of research or possibly the lack of interest of researchers in some structures. Knowing that the Brazilian Flora is very diverse and still has a great variety of species not studied, each year new substances from nature are identified, many of these, possibly with the potential to become a new drug. In Northeast Brazil is not different and among the numerous plant species studied are those that make up the genus Bauhinia that has aroused the interest of researchers, among the most popular is the Bauhinia forficata.
Toxicology & Therapeutics
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under aÂ Creative Commons Attribution LicenseÂ that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeÂ The Effect of Open AccessÂ and Benefits of Publishing Open Access).